-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P3rS1KR9888qppQeqmYNHsew213fXrMcLHMZad8LQBN19MGSkOlEal1QAM9xXtzI zHbBz8D+sDM6a1g9Gr/Pkg== 0001144204-07-043273.txt : 20070814 0001144204-07-043273.hdr.sgml : 20070814 20070814144349 ACCESSION NUMBER: 0001144204-07-043273 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20070630 FILED AS OF DATE: 20070814 DATE AS OF CHANGE: 20070814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN MEDICAL ALERT CORP CENTRAL INDEX KEY: 0000700721 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 112571221 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08635 FILM NUMBER: 071054065 BUSINESS ADDRESS: STREET 1: 3265 LAWSON BLVD CITY: OCEANSIDE STATE: NY ZIP: 11572 BUSINESS PHONE: 5165365850 MAIL ADDRESS: STREET 1: 3265 LAWSON BLVD CITY: OCEANSIDE STATE: NY ZIP: 11572 10-Q 1 v084542_10q.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
ý  
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarter ended June 30, 2007.
 
OR
 
¨  
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
 
For the transition period from ____________ to ____________
 
Commission File Number 1-8635
 
AMERICAN MEDICAL ALERT CORP.
(Exact Name of Registrant as Specified in its Charter)
 
New York
11-2571221
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification Number)
 
3265 Lawson Boulevard, Oceanside, New York 11572
(Address of principal executive offices)
(Zip Code)
 
(516) 536-5850
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x No o
 
Indicate by check mark whether registrant is a large accelerated filer, accelerated filer or non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.

Large accelerated filer o   Accelerated filer o  Non-accelerated filer  x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 on the Exchange Act)  Yes o  No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 9,310,430 shares of $.01 par value common stock as of August 10, 2007.


 
AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
 
   
INDEX
PAGE
Part I
Financial Information
 
     
   
Report of Independent Registered Public Accounting Firm
1
       
   
Condensed Consolidated Balance Sheets for June 30, 2007 and December 31, 2006
2
       
   
Condensed Consolidated Statements of Income for the Six Months Ended June 30, 2007 and 2006
4
       
   
Condensed Consolidated Statements of Income for the Three Months Ended June 30, 2007 and 2006
5
       
   
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2007 and 2006
6
       
   
Notes to Condensed Consolidated Financial Statements
8
       
   
Management’s Discussion and Analysis of Financial Condition and Results of Operations
18
       
   
Quantitative and Qualitative Disclosures About Market Risks
37
       
   
Controls and Procedures
37
       
Part II
Other Information
38
 


Report of Independent Registered Public Accounting Firm

Board of Directors and Shareholders
American Medical Alert Corp. and Subsidiaries
Oceanside, New York

We have reviewed the accompanying condensed consolidated balance sheet of American Medical Alert Corp. and Subsidiaries (the “Company”) as of June 30, 2007 and the related condensed consolidated statements of income for the six-month and three-month periods ended June 30, 2007 and 2006 and cash flows for the six-months ended June 30, 2007 and 2006. These interim financial statements are the responsibility of the Company's management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of American Medical Alert Corp. and Subsidiaries as of December 31, 2006, and the related consolidated statements of income, shareholders’ equity and cash flows for the year then ended (not presented herein), and in our report dated March 30, 2007 we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2006 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
 
/s/ Margolin, Winer & Evens LLP
 
Margolin, Winer & Evens LLP
Garden City, New York
 
August 13, 2007

1


PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
 
AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 
   
June 30, 2007 (Unaudited)
 
Dec. 31, 2006
 
ASSETS
             
CURRENT ASSETS
             
Cash
 
$
1,198,740
 
$
856,248
 
Accounts receivable
(net of allowance for doubtful accounts of $581,000 and $547,000)
   
5,661,937
   
4,920,950
 
Note receivable
   
26,290
   
25,642
 
Inventory
   
510,258
   
313,851
 
Prepaid expenses and other current assets
   
1,088,955
   
860,863
 
Deferred income taxes
   
272,000
   
239,000
 
               
Total Current Assets
   
8,758,180
   
7,216,554
 
               
FIXED ASSETS
             
(Net of accumulated depreciation and amortization)
   
9,980,137
   
9,307,912
 
               
OTHER ASSETS
             
Long-term portion of note receivable
   
34,762
   
48,071
 
Intangible assets (net of accumulated amortization of $3,801,699 and $3,194,677)
   
4,525,825
   
5,115,961
 
Goodwill (net of accumulated amortization of $58,868)
   
9,642,813
   
9,532,961
 
Other assets
   
1,066,638
   
1,386,286
 
     
15,270,038
   
16,083,279
 
TOTAL ASSETS
 
$
34,008,355
 
$
32,607,745
 
               
LIABILITIES AND SHAREHOLDERS' EQUITY
               
CURRENT LIABILITIES:
             
Current portion of long-term debt
 
$
1,529,611
 
$
1,527,327
 
Accounts payable
   
1,390,398
   
805,002
 
Accounts payable - acquisitions
   
408,085
   
477,308
 
Accrued expenses
   
1,281,216
   
1,075,256
 
Current portion of capital lease obligations
   
40,575
   
39,183
 
Deferred revenue
   
177,768
   
104,515
 
Total Current Liabilities
   
4,827,653
   
4,028,591
 
               
DEFERRED INCOME TAX LIABILITY
   
1,025,000
   
992,000
 
LONG-TERM DEBT, Net of Current Portion
   
5,011,489
   
5,677,068
 
LONG -TERM Portion of Capital Lease Obligations
   
53,799
   
74,440
 
CUSTOMER DEPOSITS
   
90,600
   
69,200
 
ACCRUED RENTAL OBLIGATION
   
413,989
   
381,256
 
OTHER LIABILITIES
   
40,000
   
40,000
 
TOTAL LIABILITIES
   
11,462,530
   
11,262,555
 
                   
COMMITMENTS AND CONTINGENT LIABILITIES
   
-
   
-
 
 
2

 
SHAREHOLDERS’ EQUITY
             
Preferred stock, $.01 par value - authorized, 1,000,000 shares; none issued and outstanding
             
Common stock, $.01 par value - authorized, 20,000,000 shares; issued 9,319,088 shares
in 2007 and 9,230,086 shares in 2006
   
93,192
   
92,302
 
Additional paid-in capital
   
15,017,015
   
14,591,238
 
Retained earnings
   
7,541,650
   
6,767,682
 
     
22,651,857
   
21,451,222
 
Less treasury stock, at cost (43,910 shares)
   
(106,032
)
 
(106,032
)
Total Shareholders’ Equity
   
22,545,825
   
21,345,190
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
 
$
34,008,355
 
$
32,607,745
 
 
             
See accompanying notes to condensed financial statements.
 
3


AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 
(Unaudited)
 
   
 Six Months Ended June 30, 
Revenues:
   
2007
   
2006
 
Services
 
$
17,401,074
 
$
14,818,137
 
Product sales
   
200,568
   
128,391
 
     
17,601,642
   
14,946,528
 
Costs and Expenses (Income):
             
Costs related to services
   
8,279,051
   
7,294,260
 
Costs of products sold
   
120,999
   
70,528
 
Selling, general and administrative expenses
   
7,922,679
   
6,690,746
 
Interest expense
   
255,136
   
175,748
 
Other income
   
(346,191
)
 
(257,297
)
               
Income before Provision for Income Taxes
   
1,369,968
   
972,543
 
               
Provision for Income Taxes
   
596,000
   
448,000
 
               
NET INCOME
 
$
773,968
 
$
524,543
 
               
Net income per share:
             
Basic
 
$
.08
 
$
.06
 
Diluted
 
$
.08
 
$
.06
 
               
Weighted average number of common shares outstanding:
             
Basic
   
9,232,958
   
8,849,678
 
               
Diluted
   
9,635,350
   
9,350,339
 
 
See accompanying notes to condensed financial statements.

4

 
AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 
(Unaudited)
 
   
Three Months Ended June 30, 
   
2007
 
 2006
 
Revenues:
             
Services
 
$
8,788,093
 
$
7,748,256
 
Product sales
   
110,713
   
48,061
 
     
8,898,806
   
7,796,317
 
Costs and Expenses (Income):
             
Costs related to services
   
4,129,948
   
3,731,278
 
Costs of products sold
   
68,792
   
26,077
 
Selling, general and administrative expenses
   
4,021,644
   
3,603,341
 
Interest expense
   
128,621
   
113,706
 
Other income
   
(176,459
)
 
(132,861
)
               
Income before Provision for Income Taxes
   
726,260
   
454,776
 
               
Provision for Income Taxes
   
319,000
   
210,000
 
               
NET INCOME
 
$
407,260
 
$
244,776
 
               
Net income per share:
             
Basic
 
$
.04
 
$
.03
 
Diluted
 
$
.04
 
$
.03
 
               
Weighted average number of common shares outstanding:
             
Basic
   
9,261,738
   
8,924,786
 
               
Diluted
   
9,692,433
   
9,429,125
 
 
See accompanying notes to condensed financial statements.
             

5

AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
   
Six Months Ended June 30
     
2007
 
 
2006
 
Cash Flows From Operating Activities:
             
               
Net income
 
$
773,968
 
$
524,543
 
               
Adjustments to reconcile net income to net cash provided by operating activities:
             
Depreciation and amortization
   
1,954,628
   
1,621,483
 
Stock compensation charge
   
144,735
   
85,000
 
Decrease (increase) in:
             
Accounts receivable
   
(740,987
)
 
(827,600
)
Inventory
   
(196,407
)
 
44,427
 
Prepaid expenses and other current assets
   
(228,092
)
 
(263,908
)
Increase (decrease) in:
             
Accounts payable, accrued expenses and other
   
845,489
   
804,094
 
Deferred revenue
   
73,253
   
80,975
 
               
Net Cash Provided by Operating Activities
   
2,626,587
   
2,069,014
 
               
Cash Flows From Investing Activities:
             
Expenditures for fixed assets
   
(2,014,778
)
 
(2,117,013
)
Repayment of notes receivable
   
12,661
   
12,045
 
Payment of accounts payable - acquisitions
   
(171,532
)
 
(310,872
)
Purchase of MD OnCall
   
-
   
(2,879,693
)
Purchases - other acquisitions
   
(7,542
)
 
(80,004
)
Deposit on equipment and software
   
-
   
(58,884
)
(Increase) decrease in other assets
   
297,708
   
(6,570
)
Payment for account acquisitions and
           
licensing agreement
   
-
   
(174,320
)
               
Net Cash (Used In) Investing Activities
   
(1,883,483
)
 
(5,615,311
)
               
Cash Flows From Financing Activities:
             
Principal payments under capital lease obligations
   
(19,249
)
 
(24,082
)
Proceeds from long-term debt
   
-
   
2,500,000
 
Repayment of long-term debt
   
(663,295
)
 
(433,509
)
Proceeds upon exercise of stock options and warrants
   
281,932
   
314,938
 
               
Net Cash Provided by (Used In) Financing Activities
   
(400,612
)
 
2,357,347
 
 
See accompanying notes to condensed financial statements.
 
6


AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(Unaudited)
 
   
Six Months Ended June 30,
     
2007
 
 
2006
 
               
Net Increase (decrease) in Cash
 
$
342,492
 
$
(1,188,950
)
               
Cash, Beginning of Period
   
856,248
   
2,638,984
 
               
Cash, End of Period
 
$
1,198,740
 
$
1,450,034
 
               
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
             
               
CASH PAID DURING THE PERIOD FOR INTEREST
 
$
232,199
 
$
124,216
 
               
CASH PAID DURING THE PERIOD FOR INCOME TAXES
 
$
408,450
 
$
1,026,575
 
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
             
               
Common Stock issued in connection with acquisition
 
$
-
 
$
343,064
 
Accounts payable due seller in connection with acquisition
   
102,309
   
343,064
 
 
See accompanying notes to condensed financial statements.
7

 
AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
 
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. General:
 
These financial statements should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2006 included in the Company’s Annual Report on Form 10-K.
 
2. Results of Operations:
 
The accompanying condensed consolidated financial statements include the accounts of American Medical Alert Corp. and its wholly-owned subsidiaries; together the “Company.” All material inter-company balances and transactions have been eliminated.
 
In the opinion of management, the accompanying unaudited condensed financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial position as of June 30, 2007 and the results of operations for the six and three months ended June 30, 2007 and 2006, and cash flows for the six months ended June 30, 2007 and 2006.
 
Except as described in Notes 3, the accounting policies used in preparing these financial statements are the same as those described in the December 31, 2006 financial statements.
 
Certain amounts in the 2006 condensed consolidated financial statements have been reclassified to conform to the 2007 presentation.
 
The results of operations for the six and three months ended June 30, 2007 are not necessarily indicative of the results to be expected for any other interim period or for the full year.
 
3. Recent Accounting Pronouncements:
 
In July 2006, FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes—an Interpretation of FASB Statement No. 109” (“FIN 48”) was issued, clarifying the accounting for uncertainty in tax positions. This Interpretation requires recognition in the financial statements of the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The provisions of FIN 48 are effective as of the beginning of our 2007 fiscal year, with the cumulative effect of the change in accounting principle recorded as an adjustment to opening retained earnings. The Company adopted FIN 48 as of January 2007 and the adoption of this Interpretation did not have a material impact on the consolidated results of operations or financial position.

8

 
In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which defines fair value, establishes guidelines for measuring fair value and expands disclosure regarding fair value measurements. SFAS No. 157 does not require new fair value measurements but rather eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. The Company does not expect the adoption of SFAS No. 157 to have a material effect on its financial statements.

In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin (SAB) No. 108, “Financial Statements - Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements.” SAB No. 108 provides interpretive guidance on how the effects of prior year uncorrected misstatements should be considered when quantifying misstatements in the current year financial statements. SAB No. 108 is effective for years ending after November 15, 2006. The adoption of the provisions of SAB No. 108 did not have a material impact on the financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” ("SFAS 159"). SFAS 159 provides companies with an option to report selected financial assets and liabilities at fair value. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities and to provide additional information that will help investors and other financial statement users to more easily understand the effect of the company's choice to use fair value on its earnings. Finally, SFAS 159 requires entities to display the fair value of those assets and liabilities for which the company has chosen to use fair value on the face of the balance sheet. SFAS 159 is effective as of the beginning of an entity's first fiscal year beginning after November 15, 2007. Early adoption is permitted as of the beginning of the previous fiscal year provided that the entity makes that choice in the first 120 days of that fiscal year and also elects to apply the provisions of SFAS 157 (see above). The Company is currently assessing the impact of SFAS 159.
 
4. Accounting for Stock-Based Compensation:
 
On January 1, 2006, the Company adopted FASB Statement No. 123 (revised 2004), “Share-Based Payment” (“Statement No. 123(R)”), which requires the measurement and recognition of compensation expense for all share-based payments to employees, including grants of stock and employee stock options, based on estimated fair values. Statement No. 123(R) supersedes the Company’s previous accounting under APB No. 25 for periods beginning in 2006. The Company adopted Statement No. 123(R) using the modified prospective transition method. The Company’s consolidated financial statements for the year ended December 31, 2006, reflects the impact of Statement No. 123(R).
 
Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Stock-based compensation expense recognized in the Company's condensed consolidated statements for the six and three months ended June 30, 2007 and 2006 includes compensation expense for share-based payment awards granted prior to, but not yet vested as of December 31 2005, based on the grant date fair value estimated in accordance with the pro forma disclosure provisions of Statement No. 123 and compensation expense for the share-based payment awards granted subsequent to December 31, 2005 based on the grant date fair value estimated in accordance with the provisions of Statement No. 123(R).
 
9

 
No options were granted during either of the six month periods ended June 30, 2007 and 2006.
 
The following tables summarize stock option activity for the six months ended June, 30, 2007 and 2006.
 
   
2007
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Average
 
Aggregate
 
 
 
 
 
Weighted
 
Remaining
 
Intrinsic
 
 
 
Number of
 
Average
 
Contractual
 
Value
 
 
 
Options
 
Option Price
 
Term (years)
 
 
 
Balance at January 1
   
1,052,818
 
$
4.02
             
Granted
   
-
   
-
             
Exercised
   
(43,425
)
 
4.55
             
Expired/Forfeited
   
(7,800
)
 
3.37
             
 
                     
 
 
Balance at June 30
   
1,001,593
 
$
4.01
   
4.68
 
$
3,989,604
 
                           
Vested and exercisable
   
1,001,593
 
$
4.01
   
4.68
 
$
3,989,604
 

   
 2006
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Average
 
Aggregate
 
 
 
 
 
Weighted
 
Remaining
 
Intrinsic
 
 
 
Number of
 
Average
 
Contractual
 
Value
 
 
 
Options
 
Option Price
 
Term (years)
 
 
 
Balance at January 1
   
1,287,283
 
$
3.56
             
Granted
   
-
   
-
             
Exercised
   
130,062
   
1.67
             
Expired/Forfeited
   
13,652
   
3.00
             
 
                     
 
 
Balance at June 30
   
1,143,569
 
$
3.79
   
5.40
 
$
2,696,223
 
                           
Vested and exercisable
   
1,143,569
 
$
3.79
   
5.40
 
$
2,696,223
 

10

 
The aggregate intrinsic value of options exercised during the six months ended June 30, 2007 and 2006 was $102,168 and $577,051, respectively. At January 1, 2006 there were 7,500 nonvested stock options outstanding. During the six months ended June 30, 2006, 2,500 options vested and 5,000 options were forfeited. There are no nonvested stock options outstanding as of June 30, 2007 and 2006.

During the six months ended June 30, 2007 and 2006 there were 24,750 and 27,750 warrants exercised, respectively, to purchase common shares of the Company.

The following table summarizes stock-based compensation expense, which is included in selling, general and administrative expense, related to all share-based payments recognized in the condensed consolidated statements of income.

   
Three Months 
Ended June 30,
 
Three Months
Ended June 30,
 
   
2007
 
2006
 
Stock options
 
$
-
 
$
1,825
 
               
Service based awards
   
42,137
   
20,000
 
Performance based awards
   
48,663
   
20,675
 
Tax benefit
   
(39,225
)
 
(19,975
)
Stock-based compensation expense, net of tax
 
$
51,575
 
$
22,525
 
 
   
Six Months
Ended June 30,
 
Six Months
Ended June 30,
 
   
2007
 
2006
 
           
Stock options
 
$
-
 
$
3,650
 
               
Service based awards
   
62,137
   
40,000
 
Performance based awards
   
71,163
   
41,350
 
Tax benefit
   
(57,500
)
 
(39,100
)
Stock-based compensation expense, net of tax
 
$
75,800
 
$
45,900
 

Service Based Awards

In January 2006 and May 2007, the Company granted 60,000 and 22,000 restricted shares, respectively, to certain executives at no cost. These shares vest ratably over periods ranging from 3 to 5 years, on December 31 of each year. As of June 30, 2007 there were 12,500 shares vested. As of June 30, 2006 no shares were vested. Fair value for restricted stock awards is based on the Company's closing common stock price on the date of grant. The aggregate grant date fair value of restricted stock was $537,100. As of June 30, 2007 and 2006, the Company had $405,350 and $320,000, respectively, of total unrecognized compensation costs related to unvested restricted stock units expected to be recognized over a weighted average period of 3.29 years.

11

 
Performance Based Awards

In January 2006 and May 2007, respectively, the Company granted share awards for 90,000 shares (up to 18,000 shares per year through December 31, 2010) and 46,000 shares (up to 11,500 shares per year through December 31, 2010) to certain executives. Vesting of such shares is contingent upon the Company achieving certain specified consolidated gross revenue and Earnings before Interest and Taxes (“EBIT”) objectives in each of the next four fiscal years ending December 31. The fair value of the performance shares is based on the closing trading value of the Company’s stock on the date of grant and assumes that performance goals will be achieved. The fair value of the shares is expensed over the performance period for those shares that are expected to ultimately vest. If such objectives are not met, no compensation cost is recognized and any recognized compensation cost is reversed. As of June 30, 2007, 18,000 shares were vested. As of June 30, 2006, no shares were vested. As of June 30, 2007 and 2006, there was $705,700 and $498,650, respectively, of total unrecognized compensation costs related to unvested share awards; that cost is expected to be recognized over a period of 3.50 years.
 
5.  Earnings Per Share:
 
Earnings per share data for the six and three months ended June 30, 2007 and 2006 is presented in conformity with SFAS No. 128, “Earnings Per Share.”

The following table is a reconciliation of the numerators and denominators in computing earnings per share:

 
Six Months June 30, 2007
 
Income
(Numerator)
 
Shares
(Denominator)
 
Per-Share
Amounts
 
Basic EPS - Income available to common stockholders
 
$
773,968
   
9,232,958
 
$
.08
 
Effect of dilutive securities -Options and warrants
   
-
   
402,392
       
Diluted EPS - Income available to common stockholders and assumed conversions
 
$
773,968
   
9,635,350
 
$
.08
 
 
Three Months June 30, 2007
                   
Basic EPS -Income available to common stockholders
 
$
407,260
   
9,261,738
 
$
.04
 
Effect of dilutive securities - Options and warrants
   
-
   
430,695
       
Diluted EPS - Income available to common stockholders and assumed conversions
 
$
407,260
   
9,692,433
 
$
.04
 
 
12

 
Six Months June 30, 2006
                   
Basic EPS - Income available to common stockholders
 
$
524,543
   
8,849,678
 
$
.06
 
Effect of dilutive securities - Options and warrants
   
-
   
500,661
       
Diluted EPS - Income available to common stockholders and assumed conversions
 
$
524,543
   
9,350,339
 
$
.06
 
                     
Three Months Ended June 30, 2006
                   
Basic EPS -Income available to common stockholders
 
$
244,776
   
8,924,786
 
$
.03
 
Effect of dilutive securities - Options and warrants
   
-
   
504,339
       
Diluted EPS - Income available to common stockholders and assumed conversions
 
$
244,776
   
9,429,125
 
$
.03
 

6. Acquisitions:

On December 21, 2006, the Company acquired substantially all of the assets of American Mediconnect, Inc. and PhoneScreen, Inc., Illinois based companies under common ownership (collectively “AMI”). American Mediconnect, Inc. is a provider of telephone after-hour answering services primarily focused on hospitals, physicians and other health care providers. PhoneScreen, Inc. is a provider of call center and compliance monitoring services to hospitals, pharmaceutical companies and clinical resource organizations. The purchase price was $2,028,830 and consisted of an initial cash payment of $1,493,730, common stock valued at $229,324 and a future cash payment of $305,776, which is due in December 2007. In addition, for the three years following the acquisition, the Company is required to pay Seller an amount equal to twenty-five (25%) percent of the cash receipts collected by the Company, excluding sales taxes, from the PhoneScreen business. For the period ended June 30, 2007, the Company recorded $102,309 due to Seller based on PhoneScreen cash receipts. The Company also incurred professional fees of approximately $65,000. A potential exists for the payment of additional purchase price consideration if certain thresholds concerning revenue and earnings of the acquired business are met as of December 31, 2007, 2008 and 2009. The results of operations of AMI are included in the Telephone Based Communications Services (“TBCS”) segment as of the date of acquisition.
 
13

 
The following table summarizes the fair values of the assets acquired as of June 30, 2007.
 
Fixed assets
 
$
175,000
 
Non-compete agreement
   
50,000
 
Customer list
   
700,000
 
Goodwill
   
1,270,087
 
         
Cost to acquire AMI
 
$
2,195,087
 

On March 10, 2006, the Company acquired substantially all of the assets of MD OnCall, a Rhode Island based company and Capitol Medical Bureau, a Maryland based company (collectively “MD OnCall”), providers of telephone after-hour answering services and stand-alone voice mail services. The purchase price was $3,382,443 and consisted of an initial cash payment of $2,696,315, common stock valued at $343,064 and future cash payments of $343,064, which were paid in full as of March 2007. The Company also recorded finder and professional fees of approximately $181,000. A potential exists for the payment of additional purchase price consideration if certain thresholds concerning revenue and earnings of the acquired business are met as of March 31, 2007, 2008 and 2009. The first threshold as of March 31, 2007 was not met. The results of operations of MD OnCall are included in the TBCS segment as of the date of acquisition.

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.

Accounts receivable
 
$
138,798
 
Fixed assets
   
260,000
 
Non-compete agreement
   
50,000
 
Customer list
   
1,050,000
 
Goodwill
   
2,255,804
 
Capital lease obligations
   
(142,625
)
Customer deposits
   
(48,200
)
         
Cost to acquire MD OnCall
 
$
3,563,777
 
 
In the case of each of the acquisitions, the Company received a third party valuation from Chartered Capital Advisors, Inc. of certain intangible assets in determining the allocation of purchase price.

The purchase price of each acquisition exceeded the fair value of the identifiable net assets acquired inasmuch as these acquisitions were consummated to enable the Company to expand its presence in the telephone answering service business into new regions. Furthermore, the acquisitions were done for the business' future cash flows and net earnings as opposed to solely for the identifiable tangible and intangible assets.
 
14

 
The results of operations for MD OnCall and American Mediconnect, Inc. are included in the condensed consolidated statements of income for the six and three months ended June 30, 2007. Unaudited pro forma results of operations for the six and three months ended June 30, 2006 as if MD OnCall and American Mediconnect, Inc. had been acquired as of the beginning of the earliest period presented are as follows. The pro forma results for the six and three months ended June 30, 2006 include estimates which management believes are reasonable.

   
Six Months Ended June 30,
 
Three Months Ended June 30,
 
   
2007
 
2006
 
2007
 
2006
 
   
Actual
 
Proforma
 
Actual
 
Proforma
 
                   
Revenue
 
$
17,602,000
 
$
16,905,000
 
$
8,899,000
 
$
8,514,000
 
Net income
   
774,000
   
523,000
   
407,000
   
240,000
 
Net income per share
                         
 
$
.08
 
$
.06
 
$
.04
 
$
.03
 
Diluted
 
$
.08
 
$
.06
 
$
.04
 
$
.03
 
 
The unaudited pro forma results of operations for the six and three months ended June 30, 2006 do not purport to represent what the Company’s results of operations would actually have been had the acquisition been effected for the period presented, or to predict the Company’s results of operations for any future period.

7.  Long-term Debt:

As of January 1, 2006 the Company had a credit facility arrangement for $4,500,000 which included a revolving credit line which permitted borrowings of $1,500,000 (based on eligible receivables as defined) and a $3,000,000 term loan payable in equal monthly principal installments of $50,000 over five years commencing January 2006.
 
In March 2006 and December 2006, the Company’s credit facility was amended whereby the Company obtained an additional $2,500,000 and $1,600,000 of term loans, the proceeds of which were utilized to finance the acquisitions of MD OnCall and American Mediconnect, Inc. These term loans are payable over five years in equal monthly principal installments of $41,666.67 and $26,666.67, respectively. Additionally, certain of the covenants were amended.
 
In December 2006, the credit facility was amended to reduce the interest rates charged by the bank such that borrowings under the term loan will bear interest at either (a) LIBOR plus 2.00% or (b) the prime rate or the federal funds effective rate plus .5%, whichever is greater, and the revolving credit line will bear interest at either (a) LIBOR plus 1.75% or (b) the prime rate or the federal funds effective rate plus .5%, whichever is greater.  The LIBOR interest rate charge shall be adjusted in .25% intervals based on the Company’s ratio of Consolidated Funded Debt to Consolidated EBITDA. The Company has the option to choose between the two interest rate options under the amended term loan and revolving credit line. Borrowings under the credit facility are collateralized by substantially all of the assets of the Company.
 
15

 
On April 30, 2007, the Company amended its credit facility whereby the term of the revolving credit line was extended through June 2010 and the amount of credit available under the revolving credit line was increased to $2,500,000.

As of June 30, 2007 and March 31, 2007, the Company was in compliance with its financial covenants in its loan agreement. As of June 30, 2006 and March 31, 2006, the Company was not in compliance with one of its financial covenants in its loan agreement. The lender waived the non-compliance as of such date and entered into an amendment to the credit facility.
 
8.  Major Customers:
 
Since 1983, the Company has provided Personal Emergency Response Systems (“PERS”) services to the City of New York’s Human Resources Administration Home Care Service Program ("HCSP"). The Company has been operating since 1993 with a contract to provide HCSP with these services, which has been extended for 1-2 year periods since 1993, the last such extension through December 31, 2006. During the six months ended June 30, 2007 and 2006, the Company’s revenue from this contract represented 7% and 9%, respectively, of its total revenue.
 
In November 2002, a new Request for Proposals (“RFP”) was issued by HRA to provide emergency response services to HCSP from April 1, 2004 through March 31, 2007. After receiving notification from the City of New York’s Human Resources Administration (“HRA”) that the Company was selected as the approved vendor under the RFP to provide PERS services to the Home Care Services Program to Medicaid Eligible individuals, the Company subsequently received notification from HRA that it canceled the RFP “in the best interest of the City of New York.” The Company was advised that the cancellation of the RFP is not related to any performance issue or negative reflection upon the Company. Concurrently, the Company was advised of HRA’s decision to issue a new contract extension to the Company through June 2005 under the terms of the contract that the Company has been operating under since 1993. The Company has since received this contract extension and also has received subsequent extensions which went through December 31, 2006. There have been no subsequent extensions beyond December 31, 2006; however, the Company continues to service this program under the same terms and conditions. In accordance with the original contract and consistent with previous extensions, HRA has the right to terminate the contract without cause or “in the best interest of the City of New York” upon thirty days written notice. In September 2006, HRA issued a bid proposal relating to the providing of the PERS services which are the subject of the Company’s contract. AMAC and several other companies submitted responses to the bid proposal and subsequently, HRA determined that AMAC's bid was the lowest qualified bid. On August 13, 2007, AMAC was notified that one of the bidders has filed an Article 78 proceeding in the Supreme Court of the State of New York, seeking a reversal of HRA's determination that AMAC was the lowest qualified bidder and that this bidder be awarded the contract to provide PERS services to HRA. This proceeding is further described in Part II-Item 1. As of August 13, 2007, AMAC has not been informed whether a new contract in favor of AMAC was registered by the City Comptroller, which is required in order for the contract to become effective. Until the new contract is registered by the Comptroller, the Company expects to continue servicing the existing contract under its current terms.
 
As of June 30, 2007 and December 31, 2006, accounts receivable from the contract represented 9% of accounts receivable and medical devices in service under the contract represented approximately 13% and 14%, respectively, of the total medical devices.
 
16

 
9.  Segment Reporting:

Effective January 1, 2007, the Company has two reportable segments, (i) Health and Safety Monitoring Systems (“HSMS”) and (ii) Telephone Based Communication Services (“TBCS”). Prior to January 1, 2007, the Company reported three reportable segments; HSMS, TBCS and Safe Com. In order to streamline the financial reporting, the Company included the activities of its Safe Com segment in its HSMS segment.
 
The table below provides a reconciliation of segment information to total consolidated information for the six and three months ended June 30, 2007 and 2006:
 
   
 2007
 
 
HSMS
 
 
TBCS
 
 
Consolidated
 
Six Months Ended June 30, 2007
                
Revenue
 
$
8,508,792
 
$
9,092,850
 
$
17,601,642
 
Income before provision for income taxes
   
538,841
   
831,127
   
1,369,968
 
Total assets
   
15,447,480
   
18,460,875
   
33,008,355
 
 
 
 
  HSMS
 
 
TBCS
 
 
Consolidated
 
Three Months Ended June 30, 2007
                
Revenue
 
$
4,409,487
 
$
4,489,319
 
$
8,898,806
 
Income before provision for income taxes
   
360,605
   
365,655
   
726,260
 
  
     
 2006
 
 
   
HSMS
 
TBCS
Consolidated
 
Six Months Ended June 30, 2006                     
Revenue
 
$
7,979,617
 
$
6,966,911
 
$
14,946,528
 
Income before provision for income taxes
   
412,369
   
560,174
   
972,543
 
Total assets
   
13,745,928
   
17,181,824
   
30,927,752
 
 
Three Months Ended June 30, 2006
   
HSMS
   
TBCS
   
Consolidated
 
Revenue
 
$
4,065,547
 
$
3,730,770
 
$
7,796,317
 
Income before provision for income taxes
   
242,576
   
212,200
   
454,776
 
 
17

 
10.   Commitments and Contingencies:
 
The Company is aware of various threatened or pending litigation claims against the Company relating to its products and services and other claims arising in the ordinary course of its business. The Company has given its insurance carrier notice of such claims and it believes there is sufficient insurance coverage to cover any such claims. Currently, there are no litigation claims for which an estimate of loss, if any, can be reasonably made as they are in the preliminary stages and therefore, no liability or corresponding insurance receivable has been recorded.

Item 2.
 Management’s Discussion and Analysis of Financial Condition and Results of Operations.
 
The following discussion and analysis provides information which management believes is relevant to an assessment and understanding of the Company’s results of operations and financial condition. This discussion and analysis should be read in conjunction with the consolidated financial statements contained in the latest Annual Report on Form 10-K dated December 31, 2006.
 
Statements contained in this Quarterly Report on Form 10-Q include “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including, in particular and without limitation, statements contained herein under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance and achievements, whether expressed or implied by such forward-looking statements, not to occur or be realized. These include uncertainties relating to government regulation, technological changes, our expansion plans, our contract with the City of New York and product liability risks. Such forward-looking statements generally are based upon the Company’s best estimates of future results, performance or achievement, based upon current conditions and the most recent results of operations. Forward-looking statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “project,” “anticipate,” “continue” or similar terms, variations of those terms or the negative of those terms.
 
You should carefully consider such risks, uncertainties and other information, disclosures and discussions which contain cautionary statements identifying important factors that could cause actual results to differ materially from those provided in the forward-looking statements. Readers should carefully review the risk factors and any other cautionary statements contained in the Company’s Annual Report on Form 10-K and other public filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
 
18


Overview:

The Company’s primary business is the provision of healthcare communication services through (1) the development, marketing and monitoring of health and safety monitoring systems (HSMS) that include personal emergency response systems, telehealth/disease management monitoring systems, medication management systems and pharmacy security monitoring systems; (2) telephony based communication services and solutions primarily for the healthcare community (“TBCS”). The Company’s products and services are primarily marketed to the healthcare community, including home care, durable medical equipment, medical facility, hospice, pharmacy, managed care and other healthcare oriented organizations. The Company also offers certain products and services directly to consumers. Until 2000, the Company’s principal business was the marketing of personal emergency response systems (PERS), a device that allows a patient to signal an emergency response center for help in the event of a debilitating illness or accident. The Company provides PERS nationwide to private pay customers, Medicaid programs as well as to healthcare related entities. In 2003, the Company initiated a relationship with a large, west coast managed care organization that recognized the value associated with provisioning PERS to its senior population and contracted AMAC to roll out its PERS product to its subscribers. Today, the number of PERS units in service under that program has more than doubled and continues to expand throughout the west coast. In February of 2007, the Company announced it had entered into an exclusive relationship with Walgreen Co. to provide the Company’s flagship personal emergency response systems under the Walgreen’s brand. Walgreens Ready Response™ Medical Alert system is currently being offered at Walgreens stores in the United States and Puerto Rico. The Company believes the Walgreen relationship will provide a significant opportunity to increase its PERS market share through Walgreen’s direct to consumer distribution channel.

In 2001, the Company entered the emerging telehealth market, an industry in its embryonic stage, recognizing the opportunity to provide new monitoring technologies to assist healthcare professionals in home-based, health management activities. The Company has made a significant investment in its initial endeavors in the disease management monitoring market. This market focuses on various technologies to permit chronic disease management through remote patient monitoring. During the last several years, the Company has learned how this market functions and has explored a variety of methods of making a meaningful entry into this market. The Company has also experienced technological difficulties with the products provided by its primary vendor, Health Hero Networks, Inc. ("HHN").  The Company commenced arbitration in April 2007 against HHN in connection with these difficulties.  Subsequent to June 30, 2007, the arbitration was settled and has been withdrawn.  AMAC has since begun working constructively with HHN, which has recently appointed a new chief executive officer.  AMAC is optimistic that, with this change in management at HHN, and HHN having committed to a plan to correct certain technical issues in its products, the Company's relationship with HHN will progress on a more positive note going forward. The Company continues to focus efforts on other alternatives to exploit this promising market. The Company believes that it is uniquely positioned to be successful in this market.

Beginning in 2000, the Company began a program of product diversification and customer base expansion to decrease its reliance on a single product line by marketing complementary call center and monitoring services to the healthcare community.
 
19

 
The Company diversified its products/service mix to include telephony based communication services (TBCS) for professionals in the healthcare community. The rationale to enter this segment had several components. These include targeting existing customer relationships, leveraging existing infrastructure capability, and establishing an additional significant revenue source. The Company’s entry into the TBCS market was accomplished initially through acquisition and later through internally generated sales growth coupled with acquisitions.
 
The Company has since further expanded its communication infrastructure and capacity and now operates a total of eight communication centers in Long Island City and Port Jefferson, New York, New Jersey, Maryland, Connecticut, Massachusetts, Rhode Island and Illinois. The TBCS segment now accounts for 52% of the Company’s revenues for the six months ended June 30, 2007.

In December 2006 the Company acquired PhoneScreen, Inc (“PhoneScreen”). PhoneScreen is a company founded 15 years ago that specializes in the recruitment of patients for clinical trials. PhoneScreen’s customers are pharmaceutical companies and Contract Research Organizations (“CRO”). CRO’s are organizations that offer pharmaceutical companies and medical entities a wide range of pharmaceutical research services which include the development and execution of clinical trials.

The Company believes it has identified other communication needs as expressed by the expanded TBCS client base. In response to these expressed needs, the Company has developed specialized healthcare communication solutions. These solutions are creating additional opportunities for long-term revenue enhancement. The Company has broadened its service offerings and is in the process of significantly expanding the TBCS reporting segment.

The Company believes that the overall mix of cash flow generating businesses from PERS and TBCS, combined with its emphasis on developing products and services in the telehealth field, provides the correct blend of stability and growth opportunity. The Company believes this strategy will enable it to maintain and increase its role in the healthcare communications field.
 
20


Components of Statements of Income by Operating Segment
The following table shows the components of the Statement of Income for the six and three months ended June 30, 2007 and 2006.
 
In thousands (000’s)
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
                                   
   
2007
 
 %
 
2006
 
 %
 
2007
 
 %
 
2006
 
 %
 
Revenues
                                                 
HSMS
   
4,410
   
50
%
 
4,065
   
52
%
 
8,509
   
48
%
 
7,980
   
53
%
TBCS
   
4,489
   
50
%
 
3,731
   
48
%
 
9,093
   
52
%
 
6,967
   
47
%
                                                   
Total Revenues
   
8,899
   
100
%
 
7,796
   
100
%
 
17,602
   
100
%
 
14,947
   
100
%
                                                   
Cost of Services and Goods Sold
                                                 
HSMS
   
1,885
   
43
%
 
1,791
   
44
%
 
3,724
   
44
%
 
3,601
   
45
%
TBCS
   
2,314
   
52
%
 
1,967
   
53
%
 
4,676
   
51
%
 
3,764
   
54
%
                                                   
Total Cost of Services and Goods Sold
   
4,199
   
47
%
 
3,758
   
48
%
 
8,400
   
48
%
 
7,365
   
49
%
                                                   
Gross Profit
                                                 
HSMS
   
2,525
   
57
%
 
2,274
   
56
%
 
4,785
   
56
%
 
4,379
   
55
%
TBCS
   
2,175
   
48
%
 
1,764
   
47
%
 
4,417
   
49
%
 
3,203
   
46
%
                                                   
Total Gross Profit
   
4,700
   
53
%
 
4,038
   
52
%
 
9,202
   
52
%
 
7,582
   
51
%
                                                   
Selling, General & Administrative
   
4,021
   
45
%
 
3,603
   
46
%
 
7,923
   
45
%
 
6,691
   
45
%
Interest Expense
   
129
   
1
%
 
113
   
1
%
 
255
   
1
%
 
176
   
1
%
Other Income
   
(176
)
 
(2
)%
 
(133
)
 
(2
)%
 
(346
)
 
(2
)%
 
(258
)
 
(2
)%
                                                   
Income before Income Taxes
   
726
   
8
%
 
455
   
6
%
 
1,370
   
8
%
 
973
   
7
%
                                                   
Provision for Income Taxes
   
319
         
210
         
596
         
448
       
                                                   
Net Income
   
407
         
245
         
774
         
525
       
Note: The percentages for Cost of Services and Goods Sold and Gross Profit are calculated based on a percentage of revenue.
 
Results of Operations:

The Company has two distinct operating business segments, which are HSMS and TBCS. Prior to January 1, 2007, the Company reported three reportable segments; HSMS, TBCS and Safe Com. In order to streamline the financial reporting the Company included the activities of its Safe Com segment in its HSMS segment.

Three Months Ended June 30, 2007 Compared to Three Months Ended June 30, 2006

Revenues:

HSMS

Revenues, which consist primarily of monthly rental revenues, increased approximately $345,000, or 8%, for the three months ended June 30, 2007 as compared to the same period in 2006. Monthly rental revenues represent revenues that are generated from the leasing and monitoring of the medical devices placed in subscribers’ residences. The increase is primarily attributed to the following factor:

§  
The Company continues to experience growth primarily in its existing customer base. The largest growth continues to be as a result of an agreement with a west coast management organization, which was executed in November 2003. The number of Personal Emergency Response Systems (“PERS”) in service under this agreement has more than doubled since its inception and has resulted in approximately $75,000 more revenue in 2007 as compared to the same period in 2006. The Company anticipates that the growth in this account will continue for the balance of 2007.

21


§  
In late 2006, the Company initiated and executed a new agreement with an agency whereby PERS were placed online. Since inception in the fourth quarter of 2006, this account has grown to approximately 1,700 subscribers and accounted for an approximate $100,000 increase in revenue during 2007 as compared to the same period in the prior year. The Company anticipates that the growth in this account will continue for the balance of 2007.

§  
In December 2006, the Company purchased approximately 1,200 subscribers utilizing PERS from a third party who previously was a customer of the Company. As a result of this transaction, the Company has generated approximately $48,000 of additional revenue for the three months ended June 30, 2007 as compared to the same period last year.

§  
In the second half of 2006, the Company increased its product sales to retirement communities. During 2006, the Company developed new software and is now selling this in conjunction with hardware to retirement communities for the purposes of monitoring their residents. This resulted in approximately a $55,000 increase in product sales for the three month period in 2007 as compared to the same period in 2006.

TBCS

The increase in revenues of approximately $758,000, or 20%, for the three months ended June 30, 2007 as compared to the same period in 2006 was primarily due to the following:

§  
In December 2006, the Company purchased the assets of American Mediconnect, Inc. and PhoneScreen, Inc. As a result of this acquisition, the Company realized approximately $615,000 of revenue in the three months ended June 30, 2007. The Company completed this acquisition to further facilitate its expansion of its telephone answering services businesses and allow them to increase its market base outside the Northeast geographical area.

Looking at 2007 with regard to the TBCS segment, the Company has shifted its focus from an acquisition driven growth strategy, to one that will place primary emphasis on internally driven business development efforts. For 2008, the Company is looking to pursue additional acquisitions in the TBCS segment which will compliment its existing call center infrastructure.

22

 
Costs Related to Services and Goods Sold:

HSMS

Costs related to services and goods increased by approximately $94,000 for the three months ended June 30, 2007 as compared to the same period in 2006, an increase of 5%, primarily due to the following:
 
§  
The relocation of the Company’s fulfillment and warehouse distribution center into Long Island City from Mt. Laurel, New Jersey during the second quarter of 2006 resulted in increased rent expense due to the Company leasing more space and paying a higher rate per square foot for rent. As part of this relocation process, the Company also transitioned the upgrade and repairs of its PERS units in-house, which required the Company to hire additional employees, including a Manager of Engineering and Fulfillment. These items accounted for approximately $45,000 of increased costs as compared to the same period in the prior year, which were primarily offset by the reduction in costs related to repairs and upgrades.

§  
During 2006 and into 2007, the Company has increased the number of personnel working in its Emergency Response Center (“ERC”) department which accounted for increased costs of approximately $40,000 in 2007 as compared to the same period in 2006. The Company hired additional personnel due to the increased volume of calls which is directly correlated to the increased subscriber base, as well as to prepare for the rollout of the Walgreen’s Ready Response™ Program, which is now in progress.

TBCS:

Costs related to services and goods increased by approximately $347,000 for the three months ended June 30, 2007 as compared to the same period in 2006, an increase of 18%, primarily due to the following:

§  
During 2006, as discussed above, the Company purchased the assets of a telephone answering service businesses which resulted in additional costs related to services for the three months ended June 30, 2007 of approximately $331,000.
 
Selling, General and Administrative Expenses:

Selling, general and administrative expenses increased by approximately $418,000 for the three months ended June 30, 2007 as compared to the same period in 2006, an increase of 12%. The increase is primarily attributable to the following:

§  
The Company incurred approximately $232,000 of additional selling, general and administrative expenses, as compared to the same period in 2006, as a result of the acquisition of a telephone answering service businesses in December 2006. The largest expenses relate to salaries and related payroll taxes and amortization relating to customer lists and non-compete agreements.

23

 
§  
The Company incurred approximately $65,000 of additional costs relating to advertising/marketing expense, as compared to the same period in 2006. This is primarily due to costs incurred with regard to an internet advertising campaign through one of its TBCS segments and costs related to the production of private labeling and marketing materials associated with the Walgreen’s Ready Response™ Program.

§  
An increase in the commission expense of approximately $32,000 is primarily due to the Company purchasing approximately 1,200 subscribers utilizing PERS from a third party in December 2006. As part of this transaction, it was agreed that the third party would continue to manage and service these accounts on behalf of the Company. As a result of this arrangement, the Company pays a commission to this third party.

There were other increases in selling, general and administrative expenses which arose out of the normal course of business such as sales and marketing salaries and travel and entertainment expense, which were partially offset by a reduction in legal fees.

Interest Expense:

Interest expense for the three months ended June 30, 2007 and 2006 was approximately $129,000 and $113,000, respectively. The increase was primarily due to the Company borrowing additional funds in December 2006 of $1,600,000 for the purpose of financing its acquisitions of AMI.

Other Income:

Other income for the three months ended June 30, 2007 and 2006 was approximately $176,000 and $133,000, respectively. Other Income for the three months ended June 30, 2007 and 2006 includes a Relocation and Employment Assistance Program (“REAP”) credit in the approximate amounts of $118,000 and $104,000, respectively. In connection with the relocation of certain operations to Long Island City, New York in April 2003, the Company became eligible for the REAP credit which is based upon the number of employees relocated to this designated REAP area. The REAP is in effect for a twelve year period; during the first five years the Company will be refunded the full amount of the eligible credit and, thereafter, the benefit will be available only as a credit against New York City income taxes.

Income Before Provision for Income Taxes:

The Company’s income before provision for income taxes for the three months ended June 30, 2007 was approximately $726,000 as compared to $455,000 for the same period in 2006. The increase of $271,000 for the three months ended June 30, 2007 primarily resulted from an increase in the Company's service revenues offset by an increase in the Company’s costs related to services and selling, general and administrative costs.

24


Six Months Ended June 30, 2007 Compared to Six Months Ended June 30, 2006

Revenues:

HSMS

Revenues, which consist primarily of monthly rental revenues, increased approximately $529,000, or 7%, for the six months ended June 30, 2007 as compared to the same period in 2006. Monthly rental revenues represent revenues that are generated from the leasing and monitoring of the medical devices placed in subscriber’s residences. The increase is primarily attributed to the following factors:

§  
The Company continues to experience growth primarily in its existing customer base. The largest growth continues to be as a result of an agreement with a west coast management organization, which was executed in November 2003. The number of Personal Emergency Response Systems (“PERS”) in service under this agreement has more than doubled since its inception and has resulted in approximately $160,000 more revenue in 2007 as compared to the same period in 2006. The Company anticipates that the growth in this account will continue for the balance of 2007.

§  
In late 2006, the Company initiated and executed a new agreement with an agency whereby PERS were placed online. Since inception in the fourth quarter of 2006, this account has grown to approximately 1,700 subscribers and accounted for an approximate $170,000 increase in revenue during 2007 as compared to the same period in the prior year. The Company anticipates that the growth in this account will continue at the same levels for the balance of 2007.

§  
In December 2006, the Company purchased approximately 1,200 subscribers utilizing PERS from a third party who previously was a customer of the Company. As a result of this transaction, the Company has generated approximately $95,000 of additional revenue for the six months ended June 30, 2007 as compared to the same period last year.

§  
In the second half of 2006, the Company increased its product sales to retirement communities. During 2006, the Company developed new software and is now selling this in conjunction with hardware to retirement communities for the purposes of monitoring their residents. This resulted in approximately a $70,000 increase in product sales in 2007 as compared to the same period in 2006.
 
 TBCS

The increase in revenues of approximately $2,126,000, or 31%, for the six months ended June 30, 2007 as compared to the same period in 2006 was primarily due to the following:

§  
During 2006, the Company purchased the assets of two separate telephone answering service businesses which resulted in additional revenue for the six months ended June 30, 2007, as compared to the same period in 2006, of approximately $2,025,000. The acquisitions were as follows:

25


o
In March 2006, the Company purchased the assets of MD OnCall and Capitol Medical Bureau (collectively “MD OnCall”). As a result of this acquisition, the Company realized approximately $640,000 of additional revenue in the first half of 2007 as compared to the same period in 2006. The Company completed this acquisition to facilitate its expansion into the Northeast geographical area.

o
In December 2006, the Company purchased the assets of American Mediconnect, Inc. and PhoneScreen, Inc. As a result of this acquisition, the Company realized approximately $1,385,000 of revenue in the first half of 2007. The Company completed this acquisition to further facilitate its expansion of its telephone answering services businesses and allow them to increase its market base outside the Northeast geographical area.

Looking at 2007 with regard to the TBCS segment, the Company has shifted its focus from an acquisition driven growth strategy, to one that will place primary emphasis on internally driven business development efforts. For 2008, the Company is looking to pursue additional acquisitions in the TBCS segment which will compliment its existing call center infrastructure.
 
Costs Related to Services and Goods Sold:

HSMS

Costs related to services and goods increased by approximately $123,000 for the six months ended June 30, 2007 as compared to the same period in 2006, an increase of 3%, primarily due to the following:

§  
The relocation of the Company’s fulfillment and warehouse distribution center into Long Island City from Mt. Laurel, New Jersey during the second quarter of 2006 resulted in increased rent expense due to the Company leasing more space and paying a higher rate per square foot for rent. As part of this relocation process, the Company also took the upgrade and repairs of its PERS units in-house, which required the Company to hire additional employees, including a Manager of Engineering and Fulfillment. These items accounted for approximately $115,000 of increased costs as compared to the same period in the prior year, which were offset by the reduction in costs related to repairs and upgrades of approximately $90,000.

§  
During 2006 and into 2007, the Company has increased the number of personnel working in its Emergency Response Center (“ERC”) department which accounted for increased costs of approximately $73,000 in 2007 as compared to the same period in 2006. The Company hired additional personnel due to the increased volume of calls which is directly correlated to the increased subscriber base, as well as to prepare for the rollout of the Walgreen’s Ready Response™ Program, which is now in progress.

26


 TBCS:

Costs related to services and goods increased by approximately $912,000 for the six months ended June 30, 2007 as compared to the same period in 2006, an increase of 24%, primarily due to the following:

§  
During 2006, as discussed above, the Company purchased the assets of two separate telephone answering service businesses which resulted in additional costs related to services for the six months ended June 30, 2007 of approximately $1,015,000. The increased costs related to services in regard to the acquisitions were as follows: MD OnCall approximated $287,000 and AMI approximated $728,000.
 
§  
During the latter part of 2006 and into 2007, the Company reduced the number of telephone answering service operators. This has been accomplished through overall efficiencies which are being realized by the Company throughout its TBCS segment. This accounted for a reduction in costs of approximately $103,000 for the period ended June 30, 2007 as compared to the same period in 2006. As the Company continues to realize these operational efficiencies, it will continue to evaluate personnel levels and continue to evaluate the consolidation strategy of its communications infrastructure, yielding greater per seat through-put with an associated reduction in overall labor expense.
 
Selling, General and Administrative Expenses:

Selling, general and administrative expenses increased by approximately $1,232,000 for the six months ended June 30, 2007 as compared to the same period in 2006, an increase of 18%. The increase is primarily attributable to the following:

§  
The Company incurred approximately $725,000 of additional selling, general and administrative expenses, as compared to the same period in 2006, as a result of the acquisition of two telephone answering service businesses during 2006. The largest expenses relate to salaries and related payroll taxes and amortization relating to customer lists and non-compete agreements.

§  
The Company incurred approximately $100,000 of additional costs relating to advertising/marketing expense, as compared to the same period in 2006. This is primarily due to costs incurred with regard to an internet advertising campaign through one of its TBCS segments and costs related to the production of private labeling and marketing materials associated with the Walgreen’s Ready Response™ Program.

27


§  
In the third quarter of 2006, the Company expanded its health benefit options to its employees. As a result of these expanded benefits, the Company experienced an increase in the number of employees participating in these plans. This, along with increased benefits costs, resulted in approximately a $75,000 increase as compared to the same period in the prior year. Although the Company believed this would reduce employee turnover, it only had a minimal impact on the rate of employee turnover. Effective July 1, 2007, the Company has modified its health benefit options and believes this will help reduce costs without impacting employee turnover.

§  
During the second quarter of 2006, the Company hired a Controller and Human Resources director. During this period the Company also relocated its accounting department from its Oceanside, New York location to its Long Island City, New York facility. As part of this process, the Company hired personnel for the LIC location while winding down operations in Oceanside and, therefore incurred additional payroll costs while transitioning this change in location. These items along with general rate increases for existing personnel accounted for approximately $125,000 of increased payroll and associated payroll tax costs as compared to the same period in the prior year. The Company believes the hiring of these employees was necessary to handle the increased workload in both the accounting and human resources departments.

§  
The Company incurred increased costs of approximately $65,000, as compared to the same period in 2006, associated with the research and development. These costs primarily associated with the new generation Med-Time dispenser, smoke detector and retirement community flush mount console unit. The Company continues to move forward with the development of these new generation products and anticipates having them available within the next three to nine months.
 
There were other increases in selling, general and administrative expenses which arose out of the normal course of business such as accounting expense, sales and marketing salaries and travel and entertainment expense which were partially offset by decreases in legal and bad debt expense.

Interest Expense:

Interest expense for the six months ended June 30, 2007 and 2006 was approximately $255,000 and $176,000, respectively. The increase was primarily due to the Company borrowing additional funds in March 2006 of $2,500,000 and December 2006 of $1,600,000 for the purpose of financing its acquisitions of MD OnCall and AMI, respectively.

Other Income:

Other income for the six months ended June 30, 2007 and 2006 was approximately $346,000 and $258,000, respectively. Other Income for the six months ended June 30, 2007 and 2006 includes a Relocation and Employment Assistance Program (“REAP”) credit in the approximate amounts of $237,000 and $202,000, respectively. In connection with the relocation of certain operations to Long Island City, New York in April 2003, the Company became eligible for the REAP credit which is based upon the number of employees relocated to this designated REAP area. The REAP is in effect for a twelve year period; during the first five years the Company will be refunded the full amount of the eligible credit and, thereafter, the benefit will be available only as a credit against New York City income taxes.

28

 
Income Before Provision for Income Taxes:

The Company’s income before provision for income taxes for the six months ended June 30, 2007 was approximately $1,370,000 as compared to $973,000 for the same period in 2006. The increase of $397,000 for the six months ended June 30, 2007 primarily resulted from an increase in the Company's service revenues offset by an increase in the Company’s costs related to services and selling, general and administrative costs.

Liquidity and Capital Resources
 
As of January 1, 2006 the Company had a credit facility arrangement for $4,500,000 which included a revolving credit line which permitted borrowings of $1,500,000 (based on eligible receivables as defined) and a $3,000,000 term loan payable in equal monthly principal installments of $50,000 over five years commencing January 2006.
 
In March 2006 and December 2006, the Company’s credit facility was amended whereby the Company obtained an additional $2,500,000 and $1,600,000 of term loans, the proceeds of which were utilized to finance the acquisitions of MD OnCall and AMI. These term loans are payable over five years in equal monthly principal installments of $41,666.67 and $26,666.67, respectively. Additionally, certain of the covenants were amended.
 
In December 2006, the credit facility was amended to reduce the interest rates charged by the bank such that borrowings under the term loan will bear interest at either (a) LIBOR plus 2.00% or (b) the prime rate or the federal funds effective rate plus .5%, whichever is greater, and the revolving credit line will bear interest at either (a) LIBOR plus 1.75% or (b) the prime rate or the federal funds effective rate plus .5%, whichever is greater.  The LIBOR interest rate charge shall be adjusted in .25% intervals based on the Company’s ratio of Consolidated Funded Debt to Consolidated EBITDA. The Company has the option to choose between the two interest rate options under the amended term loan and revolving credit line. Borrowings under the credit facility are collateralized by substantially all of the assets of the Company.
 
As of June 30, 2007 and March 31, 2007, the Company was in compliance with its financial covenants in its loan agreement. As of June 30, 2006 and March 31, 2006, the Company was not in compliance with one of its financial covenants in its loan agreement. The lender waived the non-compliance as of such date and entered into an amendment to the credit facility.

On April 30, 2007, the Company amended its credit facility whereby the term of the revolving credit line was extended through June 2010 and the amount of credit available under the revolving credit line was increased to $2,500,000.

29


The following table is a summary of contractual obligations as of June 30, 2007:
 
   
Payments Due by Period
 
Contractual Obligations
 
Total
 
Less than 1
year
 
1-3 years
 
4-5 years
 
After 5 years
 
Revolving Credit Line
 
$
850,000
       
$
850,000
             
Debt (a)
 
$
5,691,100
 
$
1,529,611
 
$
4,001,489
 
$
160,000
       
Capital Leases (b)
 
$
94,374
 
$
40,575
 
$
53,799
             
Operating Leases (c)
 
$
8,669,334
 
$
953,697
 
$
2,333,578
 
$
1,484,766
 
$
3,897,293
 
Total Contractual Obligations
 
$
15,304,808
 
$
2,523,883
 
$
7,238,866
 
$
1,644,766
 
$
3,897,293
 
 
(a)  
- Debt includes the Company’s aggregate term loans of $7,100,000 which mature in 2010 and 2011, as well as loans associated with the purchase of automobiles.
   
(b)  
- Capital lease obligations relate to the telephone answering service equipment.  These capital leases mature in the second quarter of 2009. 
 
(c)  
- Operating leases include rental of facilities at various locations within the United States. These operating leases include the rental of the Company’s call center, warehouse and the office facilities. These operating leases have various maturity dates. The Company currently leases office space from the Chairman and principal shareholder pursuant to a lease which expires in March 2008. The Company leased a second building from the Chairman and principal shareholder until October 2004, at which time the Company was released from its obligation.
 
Net cash provided by operating activities was approximately $2.6 million for the six months ended June 30, 2007, as compared to approximately $2.1 million for the same period in 2006. During 2007, increases in cash provided by operating activities from depreciation and amortization of approximately $2.0 million, increase in liabilities of $0.8 million and net earnings of approximately $0.8 million were partially offset by an increase in trade receivables of approximately $0.7 million. The components of depreciation and amortization primarily relate to the purchases of the Company’s traditional PERS product and the customer lists associated with the acquisition of telephone answering service businesses. The increase in liabilities is due to an increase in the purchase of its PERS product not paid for at June 30, 2007, accrual of 2007 taxes and timing of payments of other expenses in the ordinary course of business. The increase in trade receivables is primarily due to the Company consummating an acquisition in December 2006, which resulted in approximately $0.4 million of increased receivables through the normal course of business. Increases in cash provided by operating activities during 2006 were the result of depreciation and amortization of approximately $1.6 million, increase in liabilities of $0.8 million and net earnings of approximately $0.5 million. These increases were partially offset by an increase in trade receivables of approximately $0.8 million.
 
30

 
Net cash used in investing activities for the six months ended June 30, 2007 was approximately $1.9 million as compared to $5.6 million in the same period in 2006. The primary component of net cash used in investing activities in 2007 was capital expenditures of approximately $2.0 million. Capital expenditures in 2007 primarily related to the continued production and purchase of the traditional PERS system. The primary components of net cash used in investing activities in 2006 were the acquisition of telephone answering service businesses and capital expenditures of $3.3 and $2.1 million, respectively.
 
Cash flows for the six months ended June 30, 2007 used in financing activities were approximately $0.4 million compared to cash flows provided by financing activities of $2.4 million for the same period in 2006. The primary component of cash flow used in financing activities in 2007 was the payments of long-term debt of approximately $0.7 million. This was partially offset by proceeds received from the exercise of the Company’s stock options and warrants of approximately $0.3 million. The primary component of cash flow provided by financing activities in 2006 was proceeds received from additional borrowings of $2.5 million which were primarily used for the acquisition of a telephone answering service.
 
During the next twelve months, the Company anticipates it will make capital expenditures of approximately $3.5 - $4.0 million for the production and purchase of the traditional PERS systems and telehealth systems, enhancements to its computer operating systems and the production of its Med-Time pill dispenser (this includes outstanding purchase orders issued to purchase approximately $2,150,000 of the traditional PERS systems). This amount is subject to fluctuations based on customer demand. The Company also anticipates incurring approximately $0.2 - $0.4 million of costs relating to research and development of its telehealth product, Med-Time dispenser and retirement community flush mount console unit. In July 2005, the Company entered into a technology, licensing, development, distribution and marketing agreement with a supplier for its HSMS sector. Pursuant to this agreement the Company anticipates expending approximately $0.3 - $0.5 million over the next twelve to eighteen months.
 
As of June 30, 2007, the Company had approximately $1.2 million in cash and the Company’s working capital was approximately $3.9 million. The Company believes that with its present cash balance and with operations of the business generating positive cash flow, it will be able to meet its cash, working capital and capital expenditure needs for at least the next twelve months. The Company also has a revolving credit line, which expires in June 2010 that permits borrowings up to $2.5 million, of which $850,000 was outstanding at June 30, 2007.
 
Off-Balance Sheet Arrangements:
 
As of June 30, 2007, the Company has not entered into any off-balance sheet arrangements that are reasonably likely to have an impact on the Company’s current and future financial condition.
 
31


Other Factors:
 
On December 21, 2006, the Company acquired substantially all of the assets of American Mediconnect, Inc. and PhoneScreen, Inc., Illinois based companies under common ownership (collectively “AMI”). American Mediconnect, Inc. is a provider of telephone after-hour answering services primarily focused on hospitals, physicians and other health care providers. PhoneScreen, Inc. is a provider of call center and compliance monitoring services to hospitals, pharmaceutical companies and clinical resource organizations. The purchase price was $2,028,830 and consisted of an initial cash payment of $1,493,730, common stock valued at $229,324 and a future cash payment of $305,776, which is due in December 2007. In addition, for the three years following the acquisition, the Company is required to pay AMI an amount equal to twenty-five (25%) percent of the cash receipts collected by the Company, excluding sales taxes, from the PhoneScreen business. For the period ended June 30, 2007, the Company recorded $102,309 due to Seller based on PhoneScreen cash receipts. The Company also incurred professional fees of approximately $65,000. A potential exists for the payment of additional purchase price consideration if certain thresholds concerning revenues and earnings of the acquired business are met as of December 31, 2007, 2008 and 2009.

On March 10, 2006, the Company acquired substantially all of the assets of MD OnCall, a Rhode Island based company and Capitol Medical Bureau, a Maryland based company (collectively "MD OnCall"), providers of telephone after-hour answering services and stand-alone voice mail services. The purchase price was $3,382,443 and consisted of an initial cash payment of $2,696,315, common stock valued at $343,064, and future cash payments of $343,064, which was paid in full as of March 2007. The Company also recorded finder and professional fees of approximately $181,000. A potential exists for payments of additional purchase price consideration if certain thresholds concerning revenue and earnings of the acquired business are met as of March 31, 2007, 2008 and 2009. The first threshold as of March 31, 2007 was not met.

During 2005, the Company entered into two operating lease agreements for additional space at its Long Island City, New York location in order to consolidate its warehouse and distribution center and accounting department into this location. The leases, which commenced in January 2006 and expire in March 2018, call for minimum annual rentals of $220,000 and $115,000, respectively, and are subject to increases in accordance with the term of the agreements. The Company is also responsible for the reimbursement of real estate taxes.

On January 14, 2002, the Company entered into an operating lease agreement for space in Long Island City, New York in order to consolidate its HCI TBCS and PERS ERC/ Customer Service facilities.  The centralization of the ERC, Customer Service and H-LINK® OnCall operations has provided certain operating efficiencies and allowed for continued growth of the H-LINK and PERS divisions.  The fifteen (15) year lease term commenced in April 2003.  The lease calls for minimum annual rentals of $269,500, subject to a 3% annual increase plus reimbursement for real estate taxes.  
 
On November 1, 2001, the Company entered into a five-year Cooperative Licensing, Development, Services and Marketing Agreement with HHN (the “HHN Agreement”) pursuant to which the Company developed, with the assistance of HHN, a new integrated appliance combining the features of the Company’s PERS product with HHN’s technology. The agreement was amended on June 30, 2005 and includes an extension of the initial term for an additional three years, through October 31, 2009.
 
32


Since 1983, the Company has provided Personal Emergency Response Systems (“PERS”) services to the City of New York’s Human Resources Administration Home Care Service Program ("HCSP"). The Company has been operating since 1993 with a contract to provide HCSP with these services, which has been extended for 1-2 year periods since 1993, the last such extension through December 31, 2006. During the six months ended June 30, 2007 and 2006, the Company’s revenue from this contract represented 7% and 9% respectively, of its total revenue.
 
In November 2002, a new Request for Proposals (“RFP”) was issued by HRA to provide emergency response services to HCSP from April 1, 2004 through March 31, 2007. After receiving notification from the City of New York’s Human Resources Administration (“HRA”) that the Company was selected as the approved vendor under the RFP to provide PERS services to the Home Care Services Program to Medicaid Eligible individuals, the Company subsequently received notification from HRA that it canceled the RFP “in the best interest of the City of New York.” The Company was advised that the cancellation of the RFP is not related to any performance issue or negative reflection upon the Company. Concurrently, the Company was advised of HRA’s decision to issue a new contract extension to the Company through June 2005 under the terms of the contract that the Company has been operating under since 1993. The Company has since received this contract extension and also has received subsequent extensions which go through December 31, 2006. There have been no subsequent extensions beyond December 31, 2006; however, the Company continues to service this program under the same terms and conditions. In accordance with the original contract and consistent with previous extensions, HRA has the right to terminate the contract without cause or “in the best interest of the City of New York” upon thirty days written notice. HRA had also advised the Company that HRA plans to issue a new RFP with respect to PERS services in the future. In September 2006, HRA issued a bid proposal relating to the providing of the PERS services which are the subject of the Company’s contract. AMAC and several other companies submitted responses to the bid proposal and subsequently, HRA determined that AMAC's bid was the lowest qualified bid. On August 13, 2007, AMAC was notified that one of the bidders has filed an Article 78 proceeding in the Supreme Court of the State of New York, seeking a reversal of HRA's determination that AMAC was the lowest qualified bidder and that this bidder be awarded the contract to provide PERS services to HRA. This proceeding is further described in Part II-Item 1. As of August 13, 2007, AMAC has not been informed whether a new contract in favor of AMAC was registered by the City Comptroller, which is required in order for the contract to become effective. Until the new contract is registered by the Comptroller, the Company expects to continue servicing the existing contract under its current terms.
 
The Company cannot determine (i) how long the current contract terms will remain in effect or (ii) when or whether the new contract will be registered by the City Comptroller. While the Company has greatly reduced its dependence on revenue from HCSP, if subsequent to June 30, 2007, the Company does not maintain this contract, approximately 7% of the Company’s revenue could be lost, albeit over a protracted period, which could have a material adverse effect on operating results and cash flows. The Company continues to implement a variety of operational efficiencies, as well as continuing to enhance and diversify its other revenue streams, to offset the impact, if any, of this occurrence.
 
As of June 30, 2007 and December 31, 2006, accounts receivable from the contract represented 9% of accounts receivable and medical devices in service under the contract represented approximately 13% and 14% of medical devices, respectively.
 
33


Recent Accounting Pronouncements:
 
In July 2006, FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes—an interpretation of FASB Statement No. 109” (“FIN 48”) was issued, clarifying the accounting for uncertainty in tax positions. This Interpretation requires that we recognize in our financial statements, the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The provisions of FIN 48 are effective as of the beginning of our 2007 fiscal year, with the cumulative effect of the change in accounting principle recorded as an adjustment to opening retained earnings. The Company adapted FIN 48 as of January 2007 and the adoption of this Interpretation did not have a material impact on the consolidated results of operations or financial position.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements”, which defines fair value, establishes guidelines for measuring fair value and expands disclosure regarding fair value measurements. SFAS No. 157 does not require new fair value measurements but rather eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. We do not expect the adoption of SFAS No. 157 to have a material effect on our financial statements.

In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin (SAB) No. 108, “Financial Statements - Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”. SAB No. 108 provides interpretive guidance on how the effects of prior year uncorrected misstatements should be considered when quantifying misstatements in the current year financial statements. SAB No. 108 is effective for years ending after November 15, 2006. The adoption of the provisions of SAB No. 108 did not have a material impact on the financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities ("SFAS 159"). SFAS 159 provides companies with an option to report selected financial assets and liabilities at fair value. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities and to provide additional information that will help investors and other financial statement users to more easily understand the effect of the company's choice to use fair value on its earnings. Finally, SFAS 159 requires entities to display the fair value of those assets and liabilities for which the company has chosen to use fair value on the face of the balance sheet. SFAS 159 is effective as of the beginning of an entity's first fiscal year beginning after November 15, 2007. Early adoption is permitted as of the beginning of the previous fiscal year provided that the entity makes that choice in the first 120 days of that fiscal year and also elects to apply the provisions of SFAS 157 (see above). The Company is currently assessing the impact of SFAS 159.

34

 
Critical Accounting Policies:

In preparing the financial statements, the Company makes estimates, assumptions and judgments that can have a significant impact on our revenue, operating income and net income, as well as on the reported amounts of certain assets and liabilities on the balance sheet. The Company believes that the estimates, assumptions and judgments involved in the accounting policies described below have the greatest potential impact on its financial statements due to the materiality of the accounts involved, and therefore, considers these to be its critical accounting policies. Estimates in each of these areas are based on historical experience and a variety of assumptions that the Company believes are appropriate. Actual results may differ from these estimates.

Reserves for Uncollectible Accounts Receivable
The Company makes ongoing assumptions relating to the collectibility of its accounts receivable. The accounts receivable amount on the balance sheet includes a reserve for accounts that might not be paid. In determining the amount of the reserve, the Company considers its historical level of credit losses. The Company also makes judgments about the creditworthiness of significant customers based on ongoing credit evaluations, and it assesses current economic trends that might impact the level of credit losses in the future. The Company recorded reserves for uncollectible accounts receivable of $581,000 as of June 30, 2007, which is equal to 9.5% of total accounts receivable. While the Company believes that the current reserves are adequate to cover potential credit losses, it cannot predict future changes in the financial stability of its customers and the Company cannot guarantee that its reserves will continue to be adequate. For each 1% that actual credit losses exceed the reserves established, there would be an increase in general and administrative expenses and a reduction in reported net income of approximately $62,000. Conversely, for each 1% that actual credit losses are less than the reserve, this would decrease the Company’s general and administrative expenses and increase the reported net income by approximately $62,000.

Fixed Assets
Fixed assets are stated at cost. Depreciation for financial reporting purposes is being provided by the straight-line method over the estimated useful lives of the related assets. The valuation and classification of these assets and the assignment of useful depreciable lives involves significant judgments and the use of estimates. Fixed assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Historically, impairment losses have not been required. Any change in the assumption of estimated useful lives could either result in a decrease or increase the Company’s financial results. A decrease in estimated useful life would reduce the Company’s net income and an increase in estimated useful life would increase the Company’s net income. If the estimated useful lives of the PERS medical device were decreased by one year, the cost of goods related to services would increase and net income would decrease by approximately $185,000 per annum. Conversely, if the estimated useful lives of the PERS medical device were increased by one year, the cost of goods related to services would decrease and net income would increase by approximately $145,000 per annum.

35

 
Valuation of Goodwill
Pursuant to Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets,” goodwill and indefinite life intangible assets are no longer amortized, but are subject to annual impairment tests. To date, the Company has not been required to recognize an impairment of goodwill. The Company tests goodwill for impairment annually or more frequently when events or circumstances occur indicating goodwill might be impaired. This process involves estimating fair value using discounted cash flow analyses. Considerable management judgment is necessary to estimate discounted future cash flows. Assumptions used for these estimated cash flows were based on a combination of historical results and current internal forecasts. The Company cannot predict certain events that could adversely affect the reported value of goodwill, which totaled $9,642,813 and $9,532,961 at June 30, 2007 and December 31, 2006, respectfully. If the Company were to experience a significant adverse impact on goodwill, it would negatively impact the Company’s net income.

Accounting for Stock-Based Awards
On January 1, 2006, the Company adopted Statement of Financial Accounting Standards No. 123R, "Share-Based Payment." Prior to January 1, 2006, the Company had applied the intrinsic value method of accounting for stock options granted to our employees and directors under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," and related interpretations, as permitted by SFAS No. 123, "Accounting for Stock-Based Compensation." Accordingly, employee and director compensation expense was recognized only for those options whose exercise price was less than the market value of our common stock at the measurement date.

The Company adopted the fair value recognition provisions of SFAS No. 123R, using the modified prospective transition method. Under the modified prospective method, (i) compensation expense for share-based awards granted prior to January 1, 2006 are recognized over the remaining service period using the compensation cost calculated for pro forma disclosure purposes under SFAS No. 123 and (ii) compensation expense for all share-based awards granted subsequent to December 31, 2005 are based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123R. Results for periods prior to January 1, 2006 have not been restated. As a result of adopting SFAS No. 123R, the Company recorded a pre-tax expense of approximately $133,000 and $85,000 for stock-based compensation for the six months ended June 30, 2007 and 2006, respectively.

The determination of fair value of share-based payment awards to employees and directors on the date of grant using the Black-Scholes model is affected by the Company's stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to the expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.

36

 
Item 3.
  Quantitative and Qualitative Disclosure About Market Risk.

Market Risk Disclosure

The Company does not hold market risk-sensitive trading instruments, nor does it use financial instruments for trading purposes. Except as disclosed below in this item, all sales, operating items and balance sheet data are denominated in U.S. dollars; therefore, the Company has no significant foreign currency exchange rate risk.

In the ordinary course of its business the Company enters into commitments to purchase raw materials and finished goods over a period of time, generally six months to one year, at contracted prices. At June 30, 2007 these future commitments were not at prices in excess of current market, or in quantities in excess of normal requirements. The Company does not utilize derivative contracts either to hedge existing risks or for speculative purposes.

Interest Rate Risk

We are exposed to market risk from changes in interest rates primarily through our financing activities. Interest on our outstanding balances on our term loan and revolving credit line under our credit facility accrues at a rate of LIBOR plus 2.00% and LIBOR plus 1.75%, respectively. Our ability to carry out our business plan to finance future working capital requirements and acquisitions of TBCS businesses may be impacted if the cost of carrying debt fluctuates to the point where it becomes a burden on our resources.

Item 4.
 Controls and Procedures.
 
As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of its Chief Executive Officer and President and its Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, the Chief Executive Officer and President and the Chief Financial Officer concluded that the Company's controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed by it under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company's management, including the Chief Executive Officer and President and Chief Financial Officer of the Company, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in the Company’s internal control over financial reporting that occurred during the quarter ended June 30, 2007 that has materially affected, or is reasonably likely to affect, the Company’s internal control over financial reporting.

37

 
PART II - OTHER INFORMATION

Item 1.
  Legal Proceedings.

The Company is aware of various threatened or pending litigation claims against the Company relating to its products and services and other claims arising in the ordinary course of its business. The Company has given its insurance carrier notice of such claims and it believes there is sufficient insurance coverage to cover any such claims. Currently, there are no litigation claims for which an estimate of loss, if any, can be reasonably made as they are in the preliminary stages and therefore, no liability or corresponding insurance receivable has been recorded.
 
On April 20, 2007, the Company commenced an arbitration proceeding before the American Arbitration Association against its primary vendor of telehealth products, Health Hero Networks, Inc. (“HHN”). The Company was seeking $2.3 million in damages in connection with its claim that the products and services provided by HHN do not meet contractual specifications. In connection with these claims, the Company also sought an order compelling HHN to correct the technical defects in its products and services and honor its product warranty. On July 25, 2007, the Company and HHN agreed to resolve all claims with respect to the arbitration proceeding, and the proceeding was withdrawn.
 
On August 13, 2007, the Company was served with an Article 78 proceeding. The proceeding was filed by New York Merchants Protective Co., Inc. (the "Petitioner") in the Supreme Court of the State of New York County of New York, naming the City of New York Human Resources Administration ("HRA"), The City of New York and other city officials, as well as the Company as respondents. The Petitioner is claiming that it was the lowest qualified bidder pursuant to HRA's September 2006 PERS services bid proposal and that HRA, when disqualifying Petitioner's bid based on HRA's determination of Petitioner's qualifications, did not properly consider its experience and capacity to service the required number of PERS customers. AMAC and several other companies submitted responses to the bid proposal and subsequently, HRA determined that AMAC's bid was the lowest qualified bid. The Petitioner is seeking a judgment (i) vacating HRA's determination that the Petitioner was not a qualified bidder, (ii) annulling HRA's determination that AMAC was the lowest qualified bidder, and (iii) directing HRA to award the contract to Petitioner.

Item 2.
 Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 4.
  Submission of Matters to a Vote of Security Holders.

On July 31, 2007, the Company held its 2007 Annual Meeting of Shareholders (the “2007 Meeting”).

At the 2007 Meeting, the Company’s shareholders (i) elected seven directors to serve until the 2008 Annual Meeting of Shareholders and until their successors shall be elected and qualified, and (ii) ratified the selection of Margolin, Winer & Evens LLP as the Company’s independent auditors for the fiscal year ending December 31, 2007.

1.
The vote with respect to the election of directors was as follows:
 
Name
 
For
 
Authority Withheld
(a)    Howard M. Siegel
 
8,365,991
 
37,870
(b)    Jack Rhian
 
8,369,991
 
33,870
(c)    Frederick Siegel
 
8,064,091
 
339,770  
(d)    Ronald Levin
 
8,365,991
 
37,870
(e)    Yacov Shamash
 
8,357,991
 
45,870
(f)    John S.T. Gallagher
 
8,357,991
 
45,870
(g)    Gregory Fortunoff
 
8,350,191
 
53,670

2.
The proposal to ratify the selection of Margolin, Winer & Evens LLP as the Company’s independent auditors for the fiscal year ending December 31, 2007, was approved by the following vote:
 
For
 
Against
 
Abstain
8,328,795
 
49,673
 
25,393
 
38

 
Item 6. Exhibits.
 
 
Description
     
31.1
 
Certification of President and CEO Pursuant to Section 302 of the Sarbanes Oxley Act of 2002
31.2
 
Certification of CFO Pursuant to Section 302 of the Sarbanes Oxley Act of 2002
 
Certification of President and CEO Pursuant to Section 906 of the Sarbanes Oxley Act of 2002
32.2
 
Certification of CFO Pursuant to Section 906 of the Sarbanes Oxley Act of 2002
 
39


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
  AMERICAN MEDICAL ALERT CORP.
 
 
 
 
 
 
Dated: August 14, 2007 By:   /s/ Jack Rhian
 
  Name: Jack Rhian
  Title: Chief Executive Officer and President 
     
 
 
 
 
 
 
  By:   /s/ Richard Rallo
 
  Name: Richard Rallo
  Title: Chief Financial Officer
 
40

EX-31.1 2 v084542_ex31-1.htm Unassociated Document

Exhibit 31.1
Certification


I, Jack Rhian, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of American Medical Alert Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designedsuch internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 Date: August 14, 2007  
  /s/ Jack Rhian
  Jack Rhian
  President and
  Chief Operating Officer
     
   
 
 
 




EX-31.2 3 v084542_ex31-2.htm Unassociated Document

Exhibit 31.2
Certification

I, Richard Rallo, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of American Medical Alert Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 Date: August 14, 2007 /s/ Richard Rallo 
  Richard Rallo
  Chief Financial Officer
     
 
 

EX-32.1 4 v084542_ex32-1.htm Unassociated Document
Exhibit 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2007 (the "Report") by American Medical Alert Corp. ("Registrant"), the undersigned hereby certifies that:

1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant.

 
 
    /s/ Jack Rhian
  Jack Rhian
  Chief Executive Officer and
  President
 

A signed original of this written statement required by Section 906 has been provided to American Medical Alert Corp. and will be retained by American Medical Alert Corp. and furnished to the Securities and Exchange Commission or its staff upon request.


EX-32.2 5 v084542_ex32-2.htm Unassociated Document

Exhibit 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2007 (the "Report") by American Medical Alert Corp. ("Registrant"), the undersigned hereby certifies that:

1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant.

 
  /s/ Richard Rallo
  Richard Rallo
  Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to American Medical Alert Corp. and will be retained by American Medical Alert Corp. and furnished to the Securities and Exchange Commission or its staff upon request.




-----END PRIVACY-ENHANCED MESSAGE-----